Agape ATP (ATPC)
Market Price (9/21/2026): $2.23 | Market Cap: $2.2 MilSector: Consumer Staples | Industry: Packaged Foods & Meats
Agape ATP (ATPC)
Market Price (9/21/2026): $2.23Market Cap: $2.2 MilSector: Consumer StaplesIndustry: Packaged Foods & Meats
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Megatrend and thematic driversMegatrends include Health & Wellness Trends. Themes include Nutritional Supplements. | Weak multi-year price returns2Y Excs Rtn is -133%, 3Y Excs Rtn is -171% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -3.1 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -296% Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -11%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -15%, Rev Chg QQuarterly Revenue Change % is -93% Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -92%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -92% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -55% High stock price volatilityVol 12M is 307% Key risksATPC key risks include [1] significant financial instability raising substantial going concern doubts, Show more. |
| Megatrend and thematic driversMegatrends include Health & Wellness Trends. Themes include Nutritional Supplements. |
| Weak multi-year price returns2Y Excs Rtn is -133%, 3Y Excs Rtn is -171% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -3.1 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -296% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -11%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -15%, Rev Chg QQuarterly Revenue Change % is -93% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -92%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -92% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -55% |
| High stock price volatilityVol 12M is 307% |
| Key risksATPC key risks include [1] significant financial instability raising substantial going concern doubts, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Agape ATP (ATPC) stock has lost about 55% since 5/31/2026 because of the following key factors:
1. Significant Revenue Contraction and Operating Weakness.
Agape ATP Corporation experienced a drastic decline in revenue from its continuing operations, which plummeted by approximately 93.4% year-over-year to $13,693 in fiscal Q2 2026, down from $207,029 in the prior year. This substantial drop was attributed to the loss of green energy project revenue and lower wellness product sales, indicating a sharp contraction in core operating activities. For the first half of fiscal year 2026, total sales were $0.035281 million, a significant decrease compared to $0.24382 million a year earlier.
2. Critical Liquidity Issues and "Going Concern" Warning.
The company's financial stability has been severely impacted, highlighted by a "going concern" warning issued with its fiscal Q2 2026 results. As of June 30, 2026, Agape ATP reported meager cash and cash equivalents of only $45,480, while operating activities consumed $505,088 in cash during the first half of fiscal 2026. This limited cash position, combined with total liabilities reaching $2,973,434 (including current liabilities of $2,939,317) at the end of fiscal Q2 2026, raises significant doubts about the company's ability to continue operations without further funding.
Show more
Agape ATP (ATPC) stock has lost about 55% since 5/31/2026 because of the following key factors:
1. Significant Revenue Contraction and Operating Weakness.
Agape ATP Corporation experienced a drastic decline in revenue from its continuing operations, which plummeted by approximately 93.4% year-over-year to $13,693 in fiscal Q2 2026, down from $207,029 in the prior year. This substantial drop was attributed to the loss of green energy project revenue and lower wellness product sales, indicating a sharp contraction in core operating activities. For the first half of fiscal year 2026, total sales were $0.035281 million, a significant decrease compared to $0.24382 million a year earlier.
2. Critical Liquidity Issues and "Going Concern" Warning.
The company's financial stability has been severely impacted, highlighted by a "going concern" warning issued with its fiscal Q2 2026 results. As of June 30, 2026, Agape ATP reported meager cash and cash equivalents of only $45,480, while operating activities consumed $505,088 in cash during the first half of fiscal 2026. This limited cash position, combined with total liabilities reaching $2,973,434 (including current liabilities of $2,939,317) at the end of fiscal Q2 2026, raises significant doubts about the company's ability to continue operations without further funding.
3. Unsuccessful Business Diversification and Strategic Pivot.
Agape ATP has been attempting to diversify into renewable energy and digital wellness initiatives; however, these new ventures have not yet generated meaningful revenue, with green energy contributing $0 in fiscal Q2 2026. Concurrently, management has been strategically shifting away from its traditional network marketing model, reducing related revenue by approximately 53.5% in fiscal Q1 2026. This transition appears to have left a significant revenue gap without sufficient compensatory growth from the new business segments.
4. Negative Analyst Sentiment.
The stock has received a consensus "Sell" rating from analysts, with an average rating score of 1.00 based on the single research report available within the past 90 days. This negative professional outlook likely contributed to the downward pressure on the stock, as it signals a lack of confidence in the company's future performance.
Show less
Stock Movement Drivers
Fundamental Drivers
The -54.2% change in ATPC stock from 5/31/2026 to 9/20/2026 was primarily driven by a -45.8% change in the company's P/S Multiple.| (LTM values as of) | 5312026 | 9202026 | Change |
|---|---|---|---|
| Stock Price ($) | 4.87 | 2.23 | -54.2% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1 | 1 | -15.5% |
| P/S Multiple | 3.9 | 2.1 | -45.8% |
| Shares Outstanding (Mil) | 1 | 1 | 0.0% |
| Cumulative Contribution | -54.2% |
Market Drivers
5/31/2026 to 9/20/2026| Return | Correlation | |
|---|---|---|
| ATPC | -54.2% | |
| Market (SPY) | 0.9% | 12.8% |
| Sector (XLP) | -0.1% | 15.8% |
Fundamental Drivers
The 16.1% change in ATPC stock from 2/28/2026 to 9/20/2026 was primarily driven by a 34.8% change in the company's P/S Multiple.| (LTM values as of) | 2282026 | 9202026 | Change |
|---|---|---|---|
| Stock Price ($) | 1.92 | 2.23 | 16.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1 | 1 | -13.8% |
| P/S Multiple | 1.6 | 2.1 | 34.8% |
| Shares Outstanding (Mil) | 1 | 1 | -0.1% |
| Cumulative Contribution | 16.1% |
Market Drivers
2/28/2026 to 9/20/2026| Return | Correlation | |
|---|---|---|
| ATPC | 16.1% | |
| Market (SPY) | 11.6% | -5.9% |
| Sector (XLP) | -7.5% | 3.0% |
Fundamental Drivers
The -96.6% change in ATPC stock from 8/31/2025 to 9/20/2026 was primarily driven by a -96.2% change in the company's P/S Multiple.| (LTM values as of) | 8312025 | 9202026 | Change |
|---|---|---|---|
| Stock Price ($) | 65.50 | 2.23 | -96.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1 | 1 | -11.0% |
| P/S Multiple | 55.2 | 2.1 | -96.2% |
| Shares Outstanding (Mil) | 1 | 1 | -0.1% |
| Cumulative Contribution | -96.6% |
Market Drivers
8/31/2025 to 9/20/2026| Return | Correlation | |
|---|---|---|
| ATPC | -96.6% | |
| Market (SPY) | 19.4% | -3.3% |
| Sector (XLP) | 4.6% | 3.2% |
Fundamental Drivers
The -100.0% change in ATPC stock from 8/31/2023 to 9/20/2026 was primarily driven by a -99.3% change in the company's P/S Multiple.| (LTM values as of) | 8312023 | 9202026 | Change |
|---|---|---|---|
| Stock Price ($) | 7000.00 | 2.23 | -100.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 2 | 1 | -39.1% |
| P/S Multiple | 304.3 | 2.1 | -99.3% |
| Shares Outstanding (Mil) | 0 | 1 | -92.5% |
| Cumulative Contribution | -100.0% |
Market Drivers
8/31/2023 to 9/20/2026| Return | Correlation | |
|---|---|---|
| ATPC | -100.0% | |
| Market (SPY) | 75.6% | -0.8% |
| Sector (XLP) | 22.6% | 3.2% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| ATPC Return | 7% | -50% | -84% | -91% | -91% | -56% | -100% |
| Peers Return | 22% | 15% | -14% | -12% | -20% | 9% | -7% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 12% | 103% |
Monthly Win Rates [3] | |||||||
| ATPC Win Rate | 8% | 0% | 25% | 25% | 42% | 33% | |
| Peers Win Rate | 62% | 54% | 37% | 45% | 35% | 44% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 44% | |
Max Drawdowns [4] | |||||||
| ATPC Max Drawdown | 0% | -50% | -93% | -91% | -97% | -66% | |
| Peers Max Drawdown | -9% | -14% | -32% | -25% | -33% | -30% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: GIS, FLO, WEST, MDLZ, HSY.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 9/18/2026 (YTD)
How Low Can It Go
| Event | ATPC | S&P 500 |
|---|---|---|
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -50.0% | -24.5% |
| % Gain to Breakeven | 100.0% | 32.4% |
| Time to Breakeven | 405 days | 427 days |
In The Past
Agape ATP's stock fell -0.3% during the 2025 US Tariff Shock. Such a loss loss requires a 0.3% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | ATPC | S&P 500 |
|---|---|---|
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -50.0% | -24.5% |
| % Gain to Breakeven | 100.0% | 32.4% |
| Time to Breakeven | 405 days | 427 days |
In The Past
Agape ATP's stock fell -0.3% during the 2025 US Tariff Shock. Such a loss loss requires a 0.3% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Agape ATP (ATPC)
Agape ATP Corporation (ATPC) is a health and wellness company dedicated to enhancing human health through innovative nutritional products. The company focuses on developing and distributing a range of health supplements and functional foods designed to support various aspects of well-being.
Its core offerings include a diverse portfolio of health supplements, functional food items, and specialized beverages. These products are formulated to address key health concerns such as boosting immunity, aiding detoxification, promoting anti-aging, and improving overall vitality. The formulations often incorporate natural, plant-based ingredients, probiotics, and other beneficial nutritional compounds.
Agape ATP primarily targets health-conscious consumers and individuals seeking proactive health management. Its customer base includes those interested in preventive care, wellness enthusiasts, and older adults looking to maintain health and vitality. The company serves markets primarily in Southeast Asia, particularly Malaysia, and has expanded its reach to other international regions including the United States.
AI Analysis | Feedback
AI Analysis | Feedback
- Nutraceutical Products: Agape ATP distributes a variety of dietary supplements and health food items aimed at improving overall well-being.
- Personal Care Products: The company offers various products for personal hygiene and beauty.
AI Analysis | Feedback
Agape ATP (symbol: ATPC) operates primarily through a direct selling model. Therefore, its major customers are individuals rather than other companies. The company serves the following categories of customers:
- Independent Distributors/Members: These are individuals who sign up to be part of Agape ATP's direct selling network. They purchase products directly from the company (or its regional subsidiaries) at wholesale prices for personal consumption and for resale to end consumers. They are often motivated by both the products and the business opportunity to earn commissions.
- End Consumers: These are individuals who purchase Agape ATP's health and wellness products from the independent distributors for their personal use. While they do not directly purchase from Agape ATP, they represent the ultimate market for the company's products, driving demand through the distributor network.
AI Analysis | Feedback
AI Analysis | Feedback
Dr. Kok Choong How, Chairman of the Board, Chief Executive Officer, President, Chief Operating Officer, and Secretary
Dr. Kok Choong How is the founder of Agape ATP Corporation and was appointed Group Chief Executive Officer in June 2016.
Kam Fan Andrew Lee, Chief Financial Officer
Dr. Wilfrendo Fernando Cortizo, Ph.D., Executive Director
Wan Lock Ting, Vice President of Corporate Finance
Rose Marie Kadende Kaiser, Independent Director
Ms. Kaiser possesses over 25 years of experience in education, international development, and health coaching.
AI Analysis | Feedback
The key risks to Agape ATP (ATPC) business are:
-
Financial Instability and Profitability Challenges: Agape ATP exhibits significant financial instability, characterized by persistent profitability challenges. The company has reported negative operating and net margins, indicating substantial operational inefficiencies, and an Altman Z-Score of 1.74, placing it in the distress zone. Management has disclosed material uncertainty regarding its ability to continue as a going concern due to recurring losses and negative operating cash flow. Over the trailing twelve months, Agape ATP reported a net loss of -$2.5 million, with a net profit margin of -186.8%, largely due to high operating costs.
-
Internal Control Weaknesses and Governance Concerns: The company has disclosed material weaknesses in its internal controls, which raises the risk of accounting or disclosure errors and compromises the reliability of its financial reporting. Additionally, Agape ATP faces concentration and related-party risks, including customer/vendor concentration and substantial related-party balances and transactions that increase operational risks and governance concerns. A notable issue is a $23 million unallocated deposit with a third-party manager, raising questions about its recovery and return.
-
Nasdaq Compliance and Stock Volatility: Agape ATP has frequently struggled with Nasdaq's minimum bid price requirements, leading to delisting risks. Although the company recently regained compliance, this recurring issue highlights underlying instability. The stock has experienced extreme price fluctuations, including an 88.8% decline over the past year and significant volatility following company announcements. Such volatility increases the risk of securities litigation and may negatively impact investor confidence and future capital-raising efforts.
AI Analysis | Feedback
AI Analysis | Feedback
Agape ATP (ATPC) operates primarily within the Malaysian market, focusing on health and wellness products, health solution advisory services, and a smaller green energy segment. The company's main revenue is derived from its skin care, health, and wellness segment, which includes various supplements and wellness programs, as well as specific product lines like ENERGETIQUE (skincare) and BEAUNIQUE (nutrigenomic solutions).
The addressable markets for Agape ATP's main products and services in Malaysia are sizable:
- The overall **Health and Wellness Market in Malaysia** was valued at approximately USD 11.9 billion in 2025 and is projected to reach USD 18.0 billion by 2034, demonstrating a compound annual growth rate (CAGR) of 4.68% during this period.
- The **Skin Care Market in Malaysia** was estimated at USD 1.37 billion in 2025 and is expected to grow to USD 2.41 billion by 2030, with a CAGR of around 9.87%. Another report indicated the market size was $804.5 million in 2019, projected to reach $1.28 billion by 2027, at a CAGR of 8.1% from 2021 to 2027.
- The **Nutraceuticals and Dietary Supplements Market in Malaysia** was valued at approximately USD 1.1 billion. Other estimates include USD 1.2 billion for the Nutritional Supplements and Vitamins Market, USD 644.88 million in 2023, with a projection to reach USD 919.58 million by 2030 at a CAGR of 5.2%, and an expected value of $1 billion by 2030 from $0.6 billion in 2022, growing at a CAGR of 6.5%.
- The **Personalized Dietary Supplements Market in Malaysia** was valued at USD 84.13 million in 2025 and is projected to reach USD 272.21 million by 2032, with a CAGR of 13.46% from 2025 to 2032.
- The broader **Wellness Economy in Malaysia**, which encompasses traditional and complementary medicine along with other wellness sectors, was valued at $31.8 billion in 2025. The Traditional and Complementary Medicine (T&CM) sector in Malaysia experienced a 5.2% growth between 2019 and 2024.
AI Analysis | Feedback
Agape ATP (ATPC) is expected to drive future revenue growth over the next 2-3 years through several key initiatives, focusing on both its health and wellness products and its renewable energy solutions.
- Expansion in Renewable Energy Solutions and Market Penetration: Agape ATP plans to expand its ATPC Green Energy division, which provides sustainable energy solutions such as photovoltaic system installations and energy-saving services. The company aims to support Malaysia's clean energy transition and grow its presence in ASEAN markets. This also includes initiatives like financing the construction of EV charging stations.
- Strategic Partnerships in the Energy and Infrastructure Sector: A significant driver is the company's strategic collaboration with Dubai-based Citadel Investment, through its ATPC Green Energy division. This partnership is designed to open access to international oil, gas, and petrochemical markets, leveraging shared commercial networks and long-term supply arrangements to bolster ATPC's energy and infrastructure strategy. The company has also signed other strategic partnership agreements to advance global energy and infrastructure initiatives.
- New Product Development and Research & Development in Health and Wellness: Agape ATP intends to invest substantially in research and development to introduce groundbreaking nutritional supplements, skincare products, and wellness programs. The company seeks to enhance cellular health, immune support, and anti-aging solutions, with analysts anticipating new product launches in ATP-based therapeutics.
- Global Market Expansion: The company is focused on broader global outreach, strategically deploying resources to deliver its sustainable wellness solutions and renewable energy offerings worldwide. This global expansion aims to foster entrepreneurship and integrate renewable energy solutions into its international offerings.
AI Analysis | Feedback
Share Repurchases
- On November 22, 2023, Agape ATP Corporation authorized a share repurchase plan of up to US$1 million of its shares over the following six months.
Share Issuance
- Agape ATP Corporation closed a $6.6 million public offering on October 13, 2023, in connection with its uplisting to Nasdaq.
- Shareholders approved the potential issuance of up to $300 million of common stock under a Form S-3 registration statement at an annual meeting on January 30, 2026.
- Shareholders also approved an increase in the number of authorized shares of common stock from 500 million to 30 billion at the January 30, 2026 annual meeting.
Capital Expenditures
- Capital expenditures for Agape ATP were -$2,107 in the last 12 months (prior to March 6, 2026).
- Capital expenditures in the most recent reported quarter totaled -0.0000 million USD.
- The forecasted capital expenditures growth is -22.5%, and is expected to average -0.3% over the next five fiscal years.
Peer Outperformance in Packaged Foods & Meats
| Industry | Names | 1Y med | 3Y med | 5Y med | Top 3 by 5Y |
|---|---|---|---|---|---|
| Consumer Staples Merchandise Retail | 12 | 5.2% | 39.0% | 54.1% | NGVC 253% · VLGEA 147% · WMT 138% |
| Food Retail | 6 | -6.4% | 48.0% | 47.2% | CASY 228% · SFM 213% · KR 65% |
| Tobacco | 6 | -38.5% | 10.2% | 43.7% | PM 137% · MO 113% · TPB 61% |
| Food Distributors | 9 | -1.3% | 32.6% | 18.0% | CHEF 260% · USFD 176% · ANDE 164% |
| Soft Drinks & Non-alcoholic Beverages | 12 | -5.7% | -17.6% | 1.6% | COKE 427% · BRFH 176% · CCHGY 103% |
| Brewers | 3 | -15.8% | -34.8% | -1.2% | BUD 45% · TAP -1% · SAM -67% |
| Agricultural Products & Services | 11 | -3.4% | 4.2% | -10.4% | BG 71% · ADM 63% · INGR 29% |
| Household Products | 19 | 2.0% | -11.6% | -15.3% | IPAR 86% · ACU 85% · CL 29% |
| Personal Care Products | 4 | -3.4% | -9.0% | -25.7% | ELF 236% · PG 16% · EL -68% |
| Packaged Foods & Meats ← | 47 | -26.2% | -36.3% | -40.2% | MAMA 446% · LWAY 315% · SENEA 307% |
| Distillers & Vintners | 5 | -45.5% | -59.0% | -76.4% | STZ -38% · BF-B -58% · MGPI -76% |
| Drug Retail | 3 | -41.0% | -85.5% | -93.1% | HITI -59% · PETS -93% · SCNX -99% |
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| Can Agape ATP Stock Recover If Markets Fall? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 22.08 |
| Mkt Cap | 10.4 |
| Rev LTM | 8,694 |
| Op Inc LTM | 1,230 |
| FCF LTM | 978 |
| FCF 3Y Avg | 1,025 |
| CFO LTM | 1,324 |
| CFO 3Y Avg | 1,382 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 4.7% |
| Rev Chg 3Y Avg | 2.7% |
| Rev Chg Q | 0.1% |
| QoQ Delta Rev Chg LTM | -0.0% |
| Op Inc Chg LTM | -10.1% |
| Op Inc Chg 3Y Avg | -3.6% |
| Op Mgn LTM | 8.5% |
| Op Mgn 3Y Avg | 9.7% |
| QoQ Delta Op Mgn LTM | 0.3% |
| CFO/Rev LTM | 9.6% |
| CFO/Rev 3Y Avg | 10.3% |
| FCF/Rev LTM | 6.8% |
| FCF/Rev 3Y Avg | 7.3% |
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Skin care, Health and Wellness | 1 | 1 | 1 | ||
| Green Energy | 0 | 0 | 0 | ||
| Unallocated Expenses | 0 | 0 | |||
| Others | 0 | ||||
| ATPR Mito+ | 0 | 0 | |||
| Beta Maxx | 0 | 0 | |||
| Energetique | 0 | 0 | |||
| Health and Wellness services | 0 | 0 | |||
| Ionized Cal-Mag | 0 | 0 | |||
| Iron | 0 | 0 | |||
| LIVO 5 | 0 | ||||
| Mix Soy Protein Isolate Powder with Black Sesame | 0 | ||||
| Omega Blend | 0 | 0 | |||
| Other | 0 | ||||
| Others - Products for the provision of complementary health therapies | 1 | ||||
| Soy Protein Isolate Powder | 0 | ||||
| Survivor Select | 0 | 0 | |||
| Trim+ | 0 | 0 | |||
| Young Formula | 0 | 0 | |||
| Energized Mineral Concentrate | 0 | ||||
| Lipomask | 0 | ||||
| Organic Youth Care Cleansing Bar | 0 | ||||
| Vege Fruit Fiber | 0 | ||||
| Total | 2 | 1 | 1 | 2 | 1 |
| $ Mil | 2025 | 2024 | 2023 |
|---|---|---|---|
| Green Energy | -0 | -0 | 0 |
| Skin care, Health and Wellness | -1 | -1 | -1 |
| Unallocated Expenses | -2 | -2 | |
| Others | -1 | ||
| Total | -2 | -2 | -2 |
| $ Mil | 2025 | 2024 | 2023 |
|---|---|---|---|
| Unallocated Expenses | 24 | 2 | |
| Skin care, Health and Wellness | 1 | 1 | 1 |
| Green Energy | 0 | 0 | 0 |
| Others | 5 | ||
| Total | 25 | 3 | 6 |
Price Behavior
| Market Price | $2.23 | |
| Market Cap ($ Bil) | 0.0 | |
| First Trading Date | 10/05/2018 | |
| Distance from 52W High | -96.8% | |
| 50 Days | 200 Days | |
| DMA Price | $2.49 | $4.94 |
| DMA Trend | down | down |
| Distance from DMA | -10.4% | -54.9% |
| 3M | 1YR | |
| Volatility | 157.2% | 309.5% |
| Downside Capture | 271.45 | 92.07 |
| Upside Capture | -49.67 | -314.69 |
| Correlation (SPY) | 15.3% | -3.2% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 3.27 | 1.05 | 1.63 | -1.53 | -0.93 | -0.12 |
| Up Beta | 4.19 | 4.23 | 5.57 | -2.21 | -4.88 | -1.13 |
| Down Beta | 0.27 | 0.37 | 4.28 | 0.50 | -0.33 | 0.93 |
| Up Capture | 273% | -17% | -155% | -83% | -69% | -7% |
| Bmk +ve Days | 10 | 21 | 32 | 68 | 138 | 427 |
| Stock +ve Days | 8 | 13 | 20 | 48 | 95 | 286 |
| Down Capture | 366% | 201% | 132% | -500% | 90% | 101% |
| Bmk -ve Days | 11 | 21 | 32 | 59 | 113 | 324 |
| Stock -ve Days | 13 | 28 | 42 | 76 | 145 | 414 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with ATPC | |
|---|---|---|---|---|
| ATPC | -96.3% | 308.1% | 0.53 | - |
| Sector ETF (XLP) | 5.3% | 14.5% | 0.13 | 3.1% |
| Equity (SPY) | 16.9% | 12.9% | 0.94 | -3.3% |
| Gold (GLD) | 19.1% | 29.3% | 0.60 | 6.3% |
| Commodities (DBC) | 46.3% | 20.6% | 1.73 | 9.6% |
| Real Estate (VNQ) | 4.9% | 13.6% | 0.10 | 1.3% |
| Bitcoin (BTCUSD) | -30.6% | 44.3% | -0.70 | 0.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with ATPC | |
|---|---|---|---|---|
| ATPC | -74.1% | 223.1% | 0.07 | - |
| Sector ETF (XLP) | 5.5% | 13.7% | 0.18 | 3.1% |
| Equity (SPY) | 12.9% | 17.2% | 0.57 | -0.2% |
| Gold (GLD) | 19.1% | 18.8% | 0.83 | 5.4% |
| Commodities (DBC) | 11.2% | 19.5% | 0.45 | 7.5% |
| Real Estate (VNQ) | 1.1% | 18.8% | -0.05 | 4.4% |
| Bitcoin (BTCUSD) | 12.5% | 52.5% | 0.42 | -1.8% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with ATPC | |
|---|---|---|---|---|
| ATPC | -48.8% | 222.7% | 0.08 | - |
| Sector ETF (XLP) | 7.1% | 14.9% | 0.34 | 3.1% |
| Equity (SPY) | 15.1% | 18.0% | 0.72 | -0.1% |
| Gold (GLD) | 12.1% | 16.4% | 0.61 | 5.4% |
| Commodities (DBC) | 8.3% | 18.1% | 0.37 | 7.5% |
| Real Estate (VNQ) | 4.4% | 20.7% | 0.18 | 4.3% |
| Bitcoin (BTCUSD) | 62.6% | 66.2% | 1.02 | -1.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Updated 6/3/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 08/14/2026 | 10-Q |
| 03/31/2026 | 05/15/2026 | 10-Q |
| 12/31/2025 | 04/13/2026 | 10-K |
| 09/30/2025 | 11/13/2025 | 10-Q |
| 06/30/2025 | 08/13/2025 | 10-Q |
| 03/31/2025 | 05/15/2025 | 10-Q |
| 12/31/2024 | 03/31/2025 | 10-K |
| 09/30/2024 | 11/14/2024 | 10-Q |
| 06/30/2024 | 08/14/2024 | 10-Q |
| 03/31/2024 | 05/14/2024 | 10-Q |
| 12/31/2023 | 04/01/2024 | 10-K |
| 09/30/2023 | 11/14/2023 | 10-Q |
| 06/30/2023 | 08/14/2023 | 10-Q |
| 03/31/2023 | 05/15/2023 | 10-Q |
| 12/31/2022 | 03/31/2023 | 10-K |
| 09/30/2022 | 11/14/2022 | 10-Q |
| Report Date | Filing Date | Filing |
|---|---|---|
| 06/30/2026 | 08/14/2026 | 10-Q |
| 03/31/2026 | 05/15/2026 | 10-Q |
| 12/31/2025 | 04/13/2026 | 10-K |
| 09/30/2025 | 11/13/2025 | 10-Q |
| 06/30/2025 | 08/13/2025 | 10-Q |
| 03/31/2025 | 05/15/2025 | 10-Q |
| 12/31/2024 | 03/31/2025 | 10-K |
| 09/30/2024 | 11/14/2024 | 10-Q |
| 06/30/2024 | 08/14/2024 | 10-Q |
| 03/31/2024 | 05/14/2024 | 10-Q |
| 12/31/2023 | 04/01/2024 | 10-K |
| 09/30/2023 | 11/14/2023 | 10-Q |
| 06/30/2023 | 08/14/2023 | 10-Q |
| 03/31/2023 | 05/15/2023 | 10-Q |
| 12/31/2022 | 03/31/2023 | 10-K |
| 09/30/2022 | 11/14/2022 | 10-Q |
| 06/30/2022 | 08/11/2022 | 10-Q |
| 03/31/2022 | 05/13/2022 | 10-Q |
| 12/31/2021 | 03/28/2022 | 10-K |
| 09/30/2021 | 11/12/2021 | 10-Q |
| 06/30/2021 | 08/13/2021 | 10-Q |
| 03/31/2021 | 05/17/2021 | 10-Q |
| 12/31/2020 | 03/31/2021 | 10-K |
| 09/30/2020 | 11/16/2020 | 10-Q |
| 06/30/2020 | 08/13/2020 | 10-Q |
| 03/31/2020 | 05/14/2020 | 10-Q |
| 12/31/2019 | 03/27/2020 | 10-K |
| 09/30/2019 | 11/12/2019 | 10-Q |
Industry Resources
| Consumer Staples Resources |
| FoodNavigator |
| Consumer Goods Technology (CGT) |
| Beverage Digest |
| Packaged Foods & Meats Resources |
| USDA Data |
| Food Processing |
| Meat+Poultry |
| Just Food |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.